Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms
The purpose of this study is to determine whether the WT-1 vaccine causes an immune response and is safe. The WT-1 vaccine is made up of protein pieces that the patient's immune system can recognize as abnormal.
Un estudio de fase II de tamibaroteno en pacientes con leucemia promielocítica aguda que hayan recibido terapia previa con ATRA y trióxido de arsénico (STAR-1) - STAR-1
A Phase II, Open-label Study of INNO-206 in Patients with Recurrent Extensive Small Cell Lung Cancer after First-line Platinum-based Therapy
100 项与 Innovive Pharmaceuticals, Inc. 相关的临床结果
0 项与 Innovive Pharmaceuticals, Inc. 相关的专利(医药)
100 项与 Innovive Pharmaceuticals, Inc. 相关的药物交易
100 项与 Innovive Pharmaceuticals, Inc. 相关的转化医学